BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Back to all news

News focused on: Lab Lord S; Sandra Lord, MD; Type 1 Diabetes TrialNet; Type 1 Diabetes (T1D); Biorep Type 1 Diabetes

Blog T1D Diabetes Medical Technology

October 7, 2019

Groundbreaking Immunotherapy Can Delay Onset of Diabetes for 2 Years

September 3, 2019

Anti-CD3 drug keeps diabetes at bay

Read Nature Biotechnology news ➡

News Science in Seattle

Dr. Cate Speake Talks Biorepositories and Immune Health

News Science in Seattle

Pursuing a Revolution in IBD Treatment

Immunotherapy delays type 1 diabetes diagnosis in people at high risk

Seattle, WA - Jun 9, 2019

Immunotherapy Delays Type 1 Diabetes Diagnosis in People at High Risk

In milestone trial, experimental drug delays type 1 diabetes

Novel Type of Immune Cell Discovered in Type 1 Diabetes Patients

Parker Institute for Cancer Immunotherapy, JDRF and the Helmsley Charitable Trust Form Cancer and Diabetes Research Initiative

A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes-and no one is certain why

September 28, 2018

Low-Dose Thymoglobulin® Preserves Insulin Production in People Newly Diagnosed With Type 1 Diabetes

November 27, 2017

Insulin Pill May Delay Type 1 Diabetes in Some

Type 1 diabetes rates especially high in the Pacific Northwest

Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay

Seattle, WA - May 29, 2017

Benaroya Research Institute Scientists Unveil how a Gene Variation Drives Autoimmune Disease

1 2 3 4 5

Back to all news